Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral TherapyRubeshan Perumal, Nesri Padayatchi, Naressa Naidu et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2018Cited by 16